GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Housing remained the focus of the NDP on Tuesday, as leader Claudia Chender promised to create a compliance and enforcement ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...

Doctors say they are seeing an unusual spike in walking pneumonia cases in parts of Canada, particularly in kids, but their ...

Nova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles vaccine program for people 65 and older.

Nova Scotia’s top party leaders are talking traffic congestion, seniors’ health and rental disputes as the provincial ...

A regional public health department in Idaho will no longer provide COVID-19 vaccines after a close vote by its board.

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Should Trump be re-elected, the CDC will likely exist on a smaller budget with a reduced role internationally. Lessons from COVID-19 show this will increase Canadian vulnerabilities.

Canadian Prime Minister Justin Trudeau got his flu and COVID-19 booster shot on Monday and shared a video of himself getting ...

The City of Windsor is suing the federal government over the costs incurred due to the Freedom Convoy blockade at the ...